1,3,4-thiadiazole compounds as protein kinase inhibitors

Details 1,3,4-thiadiazole compounds as protein kinase inhibitors 1,3,4-thiadiazole compounds as protein kinase inhibitors

C - Chemistry, Metallurgy

07

D

C07D 417/10 (2006.01) A61K 31/433 (2006.01) A61P 3/10 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2583217

The invention relates to thiadiazole compound of formula (I), (see formula I) wherein R1, R2, R3, X, Y, m and n are as defined herein, useful for treating diseases mediated by protein kinase B (PKB). The invention also relates to the therapeutic use of such thiadiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.

L'invention concerne des composés de thiadiazole que l'on utilise pour traiter des maladies médiées par la protéine kinase B (PKB). L'invention concerne également l'utilisation thérapeutique de ces composés de thiadiazole ainsi que leurs compositions dans le traitement d'états pathologiques associés à la croissance cellulaire anormale, au cancer, à des inflammations, et à des troubles métaboliques.

Affiliated with

Also associated with

Rating

1,3,4-thiadiazole compounds as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,3,4-thiadiazole compounds as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3,4-thiadiazole compounds as protein kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1922847